“In control animals, CsA reduced basal anterior pituitary POMC and IL-6 mRNA and decreased plasma levels of ACTH and B. Adjuvant-injected animals that were treated with CsA showed no clinical signs of AA.”
“…,CsA inhibited the arthritis-induced increases in pituitary … IL-6 mRNA levels and in circulating ACTH and B. In vitro, CsA reduced the POMC mRNA content of cultured anterior pituitary cells and diminished … effects of corticotropin-releasing hormone (CRH) on POMC mRNA expression and ACTH secretion from these cells.”